Skip to content

FFOXFundX Future Fund Opportunities ETF

Grow my money1y track recordRanked #2,212 of 2,960 in this goal

Seeks to provide capital appreciation.

By Fund X · Launched 2025

Annual Cost

1.02%

#5,020 of 5,562 · expensive

Fund Size

$220M

#2,233 of 5,562 · mid-size

Return (1Y)Goal

+18.9%

Track Record

1 year

#4,442 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$11,848+18.5%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Cap

Smid

Strategy

Active selection

Focus

ESG, General Innovation

What it actually holds

By weight

Concentration

Top 10 holdings = 27.4% of fundwell diversified

iShares Russell Mid-Cap Growth
7.4%
iShares S&P Small-Cap 600 Grow
4.9%
Guardant Health Inc
2.1%
Ionis Pharmaceuticals Inc
2.0%
Penumbra Inc
2.0%
Globus Medical Inc
2.0%
Millicom International Cellula
1.9%
TechnipFMC PLC
1.8%
Advanced Drainage Systems Inc
1.7%
Natera Inc
1.7%

Asset allocation

Stocks
96.9%
Cash
3.2%

By sector

Technology
22.4%
Industrials
22.0%
Healthcare
21.1%
Consumer Cyclical
14.1%
Financial Services
7.8%
Consumer Defensive
5.3%
Basic Materials
3.6%
Communication
2.1%
Other
1.4%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
17.6%Moderate

Year-on-year price swings

Max drawdown
-12.4%Mild

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide capital appreciation.
Strategy
Actively managed ETF investing in equity securities of companies positioned to benefit from long-term megatrends. Focuses on themes like technology, consumer preferences, and sustainability.
Inception date
June 9, 2025
Fund family
Fund X

What's next?

You've reviewed FFOX. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19